MyCuris, one of our Silicon Valley-based portfolio companies, has been accepted into Dubai’s In5. MyCuris builds biosensors that detect temple blood pressure and breathing of user in a proprietary AR/VR headset engineered for psychotherapy and meditation (U.S. patent pending). The result is that mental health patients can virtually receive help from health professionals, unbounded by distance. You can also use it during executive coaching, mind-conditioning, etc.
Magically, through the innovative virtual reality, marginal cost drops, expanding access to care. MyCuris also creates the proprietary contents that run on these hardware devices. Our clients include military veterans undergoing mental health treatment. Congratulations to our team – Dr Abrahamson, Fazrihady, Deepak, etc.
(Making biosensors was one area I specialized during PhD in the Johns Hopkins Engineering).
Click to join Tekedia Capital and build Next Africa with min of $10,000 co-investment in startups.